107 related articles for article (PubMed ID: 22583358)
1. K-ras mutations are correlated to lymph node metastasis and tumor stage, but not to the growth pattern of colon carcinoma.
Mannan A; Hahn-Strömberg V
APMIS; 2012 Jun; 120(6):459-68. PubMed ID: 22583358
[TBL] [Abstract][Full Text] [Related]
2. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
3. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
4. Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation peptide nucleic acid clamp PCR.
Oltedal S; Gilje B; Kørner H; Aasprong OG; Tjensvoll K; Heikkilä R; Smaaland R; Nordgård O
Ann Surg; 2010 Jun; 251(6):1087-91. PubMed ID: 20485143
[TBL] [Abstract][Full Text] [Related]
5. Disseminated colorectal tumor cells in organs prone to metastasis detected by new double enriched nested-PCR in comparison with recognized assays.
Kraus MC; Linnemann U; Berger MR
Oncol Rep; 2011 May; 25(5):1421-9. PubMed ID: 21369707
[TBL] [Abstract][Full Text] [Related]
6. Detection of mutated K12-ras in histologically negative lymph nodes as an indicator of poor prognosis in stage II colorectal cancer.
Belly RT; Rosenblatt JD; Steinmann M; Toner J; Sun J; Shehadi J; Peacock JL; Raubertas RF; Jani N; Ryan CK
Clin Colorectal Cancer; 2001 Aug; 1(2):110-6. PubMed ID: 12445369
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay.
Demeure MJ; Doffek KM; Komorowski RA; Wilson SD
Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D
J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
[TBL] [Abstract][Full Text] [Related]
9. Lack of ras mutations and prediction of long-term survival in carcinoma of the colon.
Halter SA; Webb L; Rose J
Mod Pathol; 1992 Mar; 5(2):131-4. PubMed ID: 1574489
[TBL] [Abstract][Full Text] [Related]
10. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
[TBL] [Abstract][Full Text] [Related]
11. K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers.
Lee JC; Wang ST; Lai MD; Lin YJ; Yang HB
Anticancer Res; 1996; 16(6B):3839-44. PubMed ID: 9042267
[TBL] [Abstract][Full Text] [Related]
12. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
[TBL] [Abstract][Full Text] [Related]
13. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
[TBL] [Abstract][Full Text] [Related]
14. [Frequency and clinicopathological associations of K-ras mutations in Venezuelan patients with colo-rectal cancer].
Estrada P; Rojas-Atencio A; Zabala W; Borjas L; Soca L; Urdaneta K; Alvarez-Nava F; Cañizales J; Rojas J; Soto M
Invest Clin; 2009 Mar; 50(1):55-63. PubMed ID: 19418727
[TBL] [Abstract][Full Text] [Related]
15. K-ras mutation in Greek patients with poorly and moderately differenciated tumours of the lower intestinal tract.
Troungos C; Valavanis C; Kapranos N; Kittas C
Anticancer Res; 1997; 17(2B):1399-404. PubMed ID: 9137505
[TBL] [Abstract][Full Text] [Related]
16. Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study.
Samowitz WS; Curtin K; Schaffer D; Robertson M; Leppert M; Slattery ML
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1193-7. PubMed ID: 11097226
[TBL] [Abstract][Full Text] [Related]
17. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
[TBL] [Abstract][Full Text] [Related]
18. [Activation of K-ras and c-erbB-2 protooncogenes in human colonic adenocarcinomas].
Golijow C; Güerci A; Mourón S; Abba M; Dulout FN; Ottino A; Pianzola H
Acta Gastroenterol Latinoam; 2001 May; 31(2):71-6. PubMed ID: 11471321
[TBL] [Abstract][Full Text] [Related]
19. Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-RAS mutations.
Yun K; Merrie AE; Gunn J; Phillips LV; McCall JL
J Pathol; 2000 May; 191(1):21-6. PubMed ID: 10767714
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon.
Pricolo VE; Finkelstein SD; Wu TT; Keller G; Bakker A; Swalsky PA; Bland KI
Am J Surg; 1996 Jan; 171(1):41-6. PubMed ID: 8554149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
